ARTICLE | Clinical News
Rempex Pharmaceuticals preclinical data
September 17, 2012 7:00 AM UTC
In a multi-drug resistant isolate panel of Enterobacteriaceae, the minimum inhibitory concentration with antimicrobial activity against 90% of the isolates (MIC90) was 0.5 µg/mL for Carbavance vs. >32...